PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lordick, F.* ; Haffner, I.* ; Luber, B.* ; Maier, D.* ; Geier, B.* ; Raimundez-Alvarez, E. ; Hasenauer, J. ; Kretzschmar, A.K.* ; von Weikersthal, L.F.* ; Ahlborn, M.* ; Riera, J.* ; Rau, B.* ; Siegler, G.* ; Fuxius, S.* ; Decker, T.* ; Schierle, K.* ; Wittekind, C.*

High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study.

Oncol. Res. Treat. 41, 191-191 (2018)
Open Access Green as soon as Postprint is submitted to ZB.
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language english
Publication Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 2296-5270
e-ISSN 2296-5262
Journal Oncology Research and Treatment
Quellenangaben Volume: 41, Issue: , Pages: 191-191 Article Number: , Supplement: ,
Publisher Karger
Publishing Place Basel
Reviewing status Peer reviewed
Institute(s) Institute of Computational Biology (ICB)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-553800-001
WOS ID WOS:000424914300520
Erfassungsdatum 2018-03-10
[➜Report correction]